Khaled A Shaaban Selected Research

Khaled A Shaaban Research Topics

14	Neoplasms (Cancer) 02/2024 - 06/2012
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 12/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 12/2012
3	Breast Neoplasms (Breast Cancer) 08/2013 - 01/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 11/2020
1	Infections 10/2019
1	Tuberous Sclerosis (Bourneville's Disease) 01/2019
1	Lung Neoplasms (Lung Cancer) 03/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2013
1	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2013
1	Melanoma (Melanoma, Malignant) 06/2012

2	AntioxidantsIBA 06/2023 - 01/2019
2	Plicamycin FDA Link 11/2020 - 06/2012
2	Estrogens (Estrogen)FDA Link 01/2011 - 01/2011
1	AnthracyclinesIBA 02/2024
1	aklavinoneIBA 12/2022
1	auramycinoneIBA 12/2022
1	Bacterial LysatesIBA 04/2021
1	saquayamycinIBA 01/2021
1	resazurinIBA 01/2021
1	CoumarinsIBA 01/2021
1	EWS-FLI fusion proteinIBA 11/2020
1	mithramycin AIBA 11/2020
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	EstersIBA 01/2020
1	nybomycinIBA 12/2019
1	deoxynyboquinoneIBA 12/2019
1	2,5-dichloro-4-bromophenol (B 2)IBA 10/2019
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	PeroxiredoxinsIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Methicillin (Metin)FDA Link 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	GlutaredoxinsIBA 01/2019
1	PuromycinIBA 11/2018
1	SaltsIBA 01/2017
1	SalicylatesIBA 01/2017
1	SodiumIBA 01/2017
1	A-130A (A 130)IBA 01/2017
1	Phenol (Carbolic Acid)FDA Link 01/2017
1	AcidsIBA 03/2015
1	VenturicidinsIBA 03/2014
1	Rifabutin (Ansamycin)FDA Link 09/2013
1	dictyol EIBA 08/2013
1	ericifolinIBA 08/2013
1	Androgen Receptors (Androgen Receptor)IBA 08/2013
1	Anti-Anxiety Agents (Anxiolytics)IBA 02/2013
1	Hypnotics and Sedatives (Sedatives)IBA 02/2013
1	Plant Preparations (Preparation, Plant)IBA 02/2013
1	landomycin AIBA 12/2012
1	Antineoplastic Agents (Antineoplastics)IBA 06/2012

1	Therapeutics 01/2019